Document is current

Any future updates will be listed below

DNA vaccine VGX-3100 with electroporation induces regression of cervical intraepithelial neoplasia 2/3 and clears HPV infection with robust T cell responses: results of a randomized, double-blind, placebo-controlled Phase II trial

Crossref DOI link: https://doi.org/10.1186/2051-1426-2-S3-O17

Published Online: 2014-11-06

Published Print: 2014-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark